10A-AZALIDE COMPOUND CROSSLINKED AT 10A- AND 12-POSITIONS
申请人:Sugimoto Tomohiro
公开号:US20110237784A1
公开(公告)日:2011-09-29
A novel 10a-azalide compound crosslinked at the 10a- and 12-positions, which is represented by the following formula, and is effective on even
Hemophilus influenzae
, or erythromycin resistant bacteria (e.g., resistant pneumococci and streptococci).
The present invention relates to the treatment of metabolic syndrome or disorders associated with metabolic syndrome comprising administering a compound of the invention.
本发明涉及治疗代谢综合征或与代谢综合征相关的疾病,包括给予本发明的化合物。
Compositions and methods for identifying and treating dystonia disorders
申请人:DUKE UNIVERSITY
公开号:US10857145B2
公开(公告)日:2020-12-08
The present disclosure provides methods and compositions for the treatment, identification, diagnosis, and prognosis of dystonia, or dystonia related disorders.
本公开提供了治疗、识别、诊断和预后肌张力障碍或肌张力障碍相关疾病的方法和组合物。
US8293715B2
申请人:——
公开号:US8293715B2
公开(公告)日:2012-10-23
Use of Sonication for the Coupling of Sterically Hindered Substrates in the Phenolic Mitsunobu Reaction
作者:Salvatore D. Lepore、Yuanjun He
DOI:10.1021/jo0345751
日期:2003.10.1
A vast rate increase in the Mitsunobu reaction of phenols with alcohols where either or both are stericallyhindered has been achieved by the use of high concentration combined with sonication.